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Cancer of an unknown primary site (CUP) accounts for approximately 3% of all cancer cases. Among these cases, mediasti-
nal lymph node cancer is comparatively rare, and there are no established treatment methods or approaches. Excision of CUP
is feasible with the best methods. We herein report a case of mediastinal lymph node CUP resection by robot-assisted thora-
coscopic surgery (RATS). The patient was a 60-year-old man. A chest computed tomography (CT) scan identified swelling
in the mediastinal lymph node (right tracheobronchial lymph node; #4R) with another organ suspected as the site of the pri-
mary lesion, but it was not detected through positron emission tomography (PET). The patient was diagnosed with CUP with
lymph node metastasis and mediastinal lymph node dissection was performed via RATS. Histopathological examination re-
vealed desmoplasia in the lymph nodes. Immunohistochemically, the tumor was positive for CK7, TTF1, and napsin A, but
negative for CK20, CK5/6, CDX2, p40, and AFP, indicating lung-derived adenocarcinoma. In the narrow space such as the
mediastinum, RATS is a useful procedure for resectable mediastinal tumors.
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Introduction
Cancer of an unknown primary site (CUP) accounts for
approximately 3% of all the clinical cancer cases, and it
is frequently linked with mortality.
１，２
Among these cases,
mediastinal lymph nodal involvement is comparatively
rare, and there are no established therapeutic strategies.
３
To determine the primary site and select an appropriate
therapeutic regimen, biopsy and/or excision of the CUP
is required. Furthermore, the resected tissue sample can
be used for comprehensive cancer genome analysis
which will also assist with selecting an appropriate thera-
peutic option for CUP.
３，４
We herein report a case of CUP metastasizing to the
mediastinal lymph node. The lesion was successfully re-
sected by robot-assisted thoracoscopic surgery (RATS).
Histopathologically, the lung was indicated as the pri-
mary site.
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Figure　1　Preoperative imaging findings.
(A) Chest computed tomography scan showing a solitary mediastinal mass with 37 mm in maximum 
diameter without invasion surrounding tissues.
(B) 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) of the patient showing an ab-
normal uptake of FDG with a maximum standardized uptake value of 5.92 in the tumor.
(C) Coronal section of the FDG-PET showing no abnormal FDG accumulation other than the tumor. 
Case Presentation
A 60-year-old man presented with a mediastinal tumor
by chest computed tomography ( CT ) during medical
checkup and was referred to our hospital. His physical
findings were normal. He had been smoking 30 cigarettes
per day for 37 years, had a comorbidity of hypertension,
but had no past history of malignant tumors.
Although blood tests found elevated Sialyl Lewis X
(SLX) levels of 61 U/mL, both carcinoembryonic antigen
(CEA) and cytokeratin subunit 19 fragment (CYFRA)
levels were normal. No other abnormalities were identi-
fied in the blood sample.
Chest CT revealed an isolated mediastinal mass meas-
uring 37 mm in the maximum diameter without invasion
to the adjacent tissues. No abnormal shadows were iden-
tified in the lung fields ( Figure 1 A ) . 18 F-
fluorodeoxyglucose (FDG) accumulation was identified
in the tumor using FDG positron emission tomography
(PET), and the maximum standardized uptake value was
5.92. No abnormal FDG accumulation was found in
other organs (Figure 1B and C).
Endobronchial ultrasound transbronchial needle aspi-
ration (EBUS-TBNA) was performed and he was diag-
nosed with adenocarcinoma. Since no primary site organ
could be identified, the diagnosis was mediastinal lymph
node CUP, and robot-assisted thoracoscopic surgery
(RATS) was performed.
The patient was intubated with a double-lumen en-
dotracheal tube for one-lung ventilation under general
anesthesia, and placed in a left lateral decubitus position.
RATS excision of the mediastinal tumor was performed
with four port incisions and a 4-cm utility thoracotomy as
an assistant port. The da Vinci Surgical System (Model
Xi; Intuitive Surgical, Inc, Sunnyvale, CA, USA) was
used. RATS began with a total of four 8-mm ports in-
serted in the 7th intercostal space (ICS) at the anterior
side as the 1st arm, in the 8th ICS mid-axillary line as the
2nd arm, in the 8th posterior axillary line as the 3rd arm,
and in the 8th posterior side as the 4th arm, plus an assis-
tant port in the 4th ICS (Figure 2). A robotic arm was
mounted to the port in the 8th ICS, with Cadiere grasping
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Figure　2　Schematic illustration of four port incisions and a 
4-cm utility thoracotomy as an assistant port.
A total of four 8-mm ports (circle) were inserted in anterior to 7th 
intercostal space (ICS), 8th ICS mid-axillary line, posterior axil-
lary line, and posterior. An assistant port (line) was made at 4th 
ICS.
ICS, intercostal space; A, assistant port; C, camera. 
forceps on the 1st arm, bipolar fenestrated grasping for-
ceps on the 2nd arm, and monopolar spatula on the 4th
arm. The camera scope was inserted into the 8th ICS
mid-axillary line port and was used for 30° oblique view-
ing. No adhesions were found within the right thoracic
cavity, and there were no abnormalities in the lungs. The
tumor was located in the right lower paratracheal lymph
nodes (4R) on the cranial side of the azygos vein (Fig-
ure 3A). After the pleura was incised in a cephalad direc-
tion, the azygos vein and tumor were exposed. For ampu-
tating the azygos vein, an EndoWrist stapler was used
through the 4th arm port (Figure 3B). The mediastinal
fat pad including the tumor was dissected off the superior
vena cava and anterolateral tracheal surface ( Fig-
ure 3C and D ) . The resected mediastinal tumor was
placed in a bag and removed through the assistant port,
followed by the insertion of a 21-Fr silicon tube through
the camera port. The tumor was measured 4.5 × 3.5 ×
2.5 cm (Figure 4). Macroscopic finding of the tumor was
yellow-whitish surface.
Histopathologically, the resected lymph node was oc-
cupied by tumor cells with a solid architecture. The tu-
mor cells were large in size and polygonal in shape.
Their nuclei were large with a vesicular appearance and
prominent nucleoli. The cytoplasm was pale. Based on
these findings, a germ cell tumor, lymphoma, and malig-
nant melanoma were considered as differential diagnostic
candidates along with metastatic carcinoma (Figure 5A).
Immunohistologically, the tumor cells were positive for
cytokeratin (CK) 7, thyroid transcription factor-1 (TTF-
1), and napsin A, while negative for CK20, CK5/6, cau-
dal related homeobox gene type 2(CDX2, p40, and α-
fetoprotein (AFP) (Figure 5B-F). Based on these find-
ings, he was diagnosed with metastatic adenocarcinoma,
the primary site of which was considered to be the lung.
Genetic tests failed to reveal any mutation of epidermal
growth factor receptor (EGFR) and translocation involv-
ing anaplastic lymphoma kinase (ALK) and c-ros onco-
gene 1 (ROS1). The postoperative course was uneventful.
The chest tube was removed on the 4th day, and he was
discharged on the 7th day after surgery. Postoperative ad-
juvant chemotherapy was received according to the treat-
ment for lung cancer. The patient showed no evidence of
recurrence at the 15-month follow-up.
Discussion
CUP refers to metastasized cancer for which the primary
site cannot be identified. This condition is usually seen in
the liver, lungs, and bones. In this case, the mediastinal
lymph nodes showed isolated metastasis, although it ac-
counts for just 1.5% of all CUP involvements.
５
Most
common histological types of CUP are adenocarcinoma,
followed by undifferentiated carcinoma and squamous
cell carcinoma.
１，６
Sampling procedures of mediastinal lymph node CUP
include bronchoscopy, thoracoscopy, mediastinoscopy,
and surgical procedures. Differentiating diagnosis be-
tween CUP, other tumors originating in the mediastinum,
and malignant lymphoma is essential. In addition, since
future developments in cancer genome analysis are help-
ful for both the diagnosis and treatment selection of
CUP,
２
sampling of sufficient tumor tissue is important.
As a result, biopsy and/or excision of mediastinal tumors
are the best methods.
The robotic surgical system provides a 3-dimensional
view and dedicated robotic instruments that have com-
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Figure　3　The intraoperative screenshot of the robot-assisted thoracoscopic surgery (RATS).
(A) The tumor (*) was located in right lower paratracheal lymph nodes (4R) on the cranial side of the 
azygos vein.
(B) After the pleura was incised in a cephalad direction, azygos vein (white arrow) and the tumor were 
exposed. The azygos vein was amputated by robotic stapler.
(C) The mediastinal fat pad including the tumor was dissected off superior vena cava.
(D) The mediastinal fat pad including the tumor was dissected off the anterolateral tracheal surface and 
removed. 
Figure　4　The intraoperative view of the tumor.
The intraoperative view of the tumor was extracted from digital 
video data taken during the operation and was provided on a per-
sonal computer after operation. 
fortable motions with 7 degrees of freedom in the tho-
racic cavity. Although the mediastinum with lymph node
is tightly packed with intertwined organs, the robotic sur-
gical system allowed for a smooth and natural manipula-
tion when performing surgical dissection. Especially,
compared to the traditional video-assisted thoracic sur-
gery (VATS) approach, robot-assisted surgery has been
reported to be more effective for mediastinal lymph node
dissection.
７-９
Pathologically, seminoma, lymphoma, and malignant
melanoma were considered as differential diagnostic can-
didates along with metastatic carcinoma. To determine
the histological type and tumor origin, immunostaining
was performed. Combined immunostainings for CK7 and
CK20 are frequently employed to determine the primary
site, especially of adenocarcinoma. TTF-1, SPA, and
napsin A are characteristically positive for lung cancer,
especially adenocarcinoma.
１０，１１
In this case, the primary
lesion site was in the lungs because the tumor was posi-
tive for TTF-1, CK7, and napsin A but negative for
CK20.
Although most CUP are considered to signify ad-
vanced stage cancers, adjuvant chemotherapy following
surgical resection is necessary for CUP. For mediastinal
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Figure　5　Microscopic findings of the resected specimen.
(A) Hematoxylin and eosin staining showing desmoplasia in the lymph nodes.
(B-F) Immunohistochemical examination revealing positive stain in (B) cytokeratin (CK) 7,  (C) Thy-
roid transcription factor-1 (TTF-1), and (D) napsin A, and negative stain in (E) α-fetoprotein (AFP) 
and (F) CK20. 
lymph node CUP, there are various postoperative care
regimens. A variety of surgical treatments, such as pul-
monary lobectomy and lymph node dissection are used.
Observation and other treatments, including adjuvant
chemotherapy, radiotherapy, or a combination of both
chemotherapy and radiotherapy, are performed after sur-
gical resection.
３，１２，１３
The 5-year survival rate for CUP has
been reported to range from 2-6%, but there are also re-
ports that isolated mediastinal lymph node CUP has a
comparatively better prognosis.
１３
In some reports, careful
postsurgical investigation is required for mass shadows




RATS tumor resection was performed for mediastinal
lymph node CUP. In narrow spaces, such as the mediasti-
num, RATS is a useful procedure for resectable CUP
with mediastinal metastasis for the diagnosis and estab-
lishment of a therapeutic strategy.
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